Publications found:
1,182
Sort by:
Global AR PROTAC Drugs for Cancer Market Growth 2026-2032
US$ 3,660.00
The global AR PROTAC Drugs for Cancer market size is predicted to grow from US$ million in 2025 to US$ 783 million in 2032; it is expected to grow at a CAGR of 26.3% from 2026 to 2032. No AR PROTAC Dr...
May 2026
97 pages
Global AR Targeted PROTAC Drugs Market Growth 2026-2032
US$ 3,660.00
The global AR Targeted PROTAC Drugs market size is predicted to grow from US$ million in 2025 to US$ 626 million in 2032; it is expected to grow at a CAGR of 22.1% from 2026 to 2032. No AR Targeted PR...
May 2026
92 pages
Targeted Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Therapy Type (Hormone Therapies, Monoclonal Antibodies, Signal Transduction Inhibitors, Gene Expression Modulators, Apoptosis Inhibitors, Others), By Disease Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma, Lymphoma, Others), By End User (Hospitals & Clinics, Cancer & Radiation Therapy Centers, Academic & Research Institutions), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global targeted cancer therapy market is anticipated to expand from USD 16.82 billion in 2025 to USD 26.26 billion by 2031, reflecting a compound annual growth rate of 7.71%. This precise medical...
May 2026
188 pages
Global AR PROTAC Degraders Market Growth 2026-2032
US$ 3,660.00
The global AR PROTAC Degraders market size is predicted to grow from US$ million in 2025 to US$ 497 million in 2032; it is expected to grow at a CAGR of 19.3% from 2026 to 2032. No AR PROTAC Degraders...
April 2026
94 pages
Global AR PROTAC Drugs Market Growth 2026-2032
US$ 3,660.00
The global AR PROTAC Drugs market size is predicted to grow from US$ million in 2025 to US$ 744 million in 2032; it is expected to grow at a CAGR of 25.2% from 2026 to 2032. No AR PROTAC drugs have ye...
April 2026
101 pages
Europe Cancer Drugs Market Size and Forecast (2021 - 2031)
US$ 3,450.00
The Europe Cancer Drugs Market is projected to grow significantly, reaching approximately US$ 147,900.6 million by 2031, up from US$ 67,482.3 million in 2024. This growth represents a compound annual...
April 2026
282 pages
Personalized Oncology & Immunotherapy Market Forecasts to 2034 – Global Analysis By Therapy Type (Immune Checkpoint Inhibitors, CAR-T Cell Therapy, Cancer Vaccines, Monoclonal Antibodies, Targeted Small Molecule Therapy and Other Therapy Types), Biomarker, Cancer Type, Technology, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Personalized Oncology & Immunotherapy Market is accounted for $180 billion in 2026 and is expected to reach $420 billion by 2034 growing at a CAGR of 11% durin...
April 2026
200 pages
Androgen Receptor Inhibitor Market 2026
US$ 2,999.00
The Androgen Receptor Inhibitor Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
April 2026
223 pages
Epithelioid Sarcoma Treatment Market - 2025-2033
US$ 2,999.00
The Epithelioid Sarcoma Treatment Market was valued at US$ 1.58 billion in 2025 and is anticipated to reach US$ 3.19 billion by 2033, at a CAGR of 0.091 from 2026 to 2032. The report delivers in-depth...
April 2026
207 pages
Pediatric Oncology Drugs Market 2026
US$ 2,999.00
The Pediatric Oncology Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
April 2026
210 pages
Prostate Cancer Market - 2025
US$ 2,999.00
The Prostate Cancer Market was valued at US$ 14.25 billion in 2025 and is anticipated to reach by , at a CAGR of 0.078 from 2026 to 2032. The report delivers in-depth insights into key market dynamics...
April 2026
200 pages